First-line therapy: Latanoprost approved for glaucoma use in Europe


Peapack, NJ-Regulatory authorities governing Europe's Mutual Recognition Process have approved the use of latanoprost ophthalmic solution (Xalatan) as a first-line treatment for lowering IOP in patients with open-angle glaucoma and ocular hypertension.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.